Palabras clave
Biopoder
Biomercado
Salud Pública
Salud Global
Cómo citar
Resumen
Este artículo examina la intersección entre biopoder, biomercado y salud global, centrándose en el caso de los cigarrillos electrónicos. Siguiendo la conceptualización de Foucault, se analiza la evolución del biopoder desde un control absoluto sobre la vida en la época premoderna hacia una forma más sutil de "hacer vivir y dejar morir" en la era moderna, enfocada en la administración y reproducción de la vida para el beneficio del capitalismo emergente. El análisis destaca cómo las industrias tabacaleras han capitalizado el desarrollo del cigarrillo electrónico, presentándolo como una alternativa más segura al tabaco tradicional. A través de estrategias de marketing, financiación de investigaciones y lobby político, estas empresas buscan influir en la percepción pública y desafiar la regulación gubernamental. La introducción del cigarrillo electrónico ha generado un nuevo escenario donde las compañías tabacaleras, históricamente vinculadas a problemas de salud pública, ahora se posicionan como parte de la solución al consumo de tabaco. No obstante, se enfatiza la incertidumbre sobre la seguridad y efectividad a largo plazo de los cigarrillos electrónicos como herramienta para dejar de fumar. A pesar de esta ambigüedad, las industrias tabacaleras continúan promoviendo sus productos para establecerse como proveedores de alternativas más seguras e influir en la toma de decisiones gubernamentales. Este fenómeno ilustra la compleja intersección entre biopoder, biomercado y salud global, donde los intereses comerciales y las preocupaciones de salud pública se entrelazan de manera conflictiva. El artículo propone abordar estas dinámicas desde una perspectiva activa y adaptable para proteger la salud poblacional frente a intereses comerciales.
Citas
1 Raveendran A, Bazzul J. Socialized medicine has always been political: COVID-19, science and biopower in India. Cult Stud Sci Educ. 2021; 16: 995–1013. doi: https://doi.org/10.1007/s11422-021-10093-1
2 McCann A. Biopolitics and the Potentia of Literature. In: West-Pavlov R, ed. The Global South and Literature. Cambridge: Cambridge University Press. 2018: 134–44. doi: https://doi.org/10.1017/9781108231930.011
3 Salgues B. 9 - Belief, Myth and Biopower. In: Salgues B, Health Industrialization. 2016: 117–37. doi: https://doi.org/10.1016/B978-1-78548-147-5.50009-6
4 Krieger N. Who and What Is a “Population”? Historical Debates, Current Controversies, and Implications for Understanding “Population Health” and Rectifying Health Inequities. Milbank Q. 2012; 90: 634–81. doi: https://doi.org/10.1111/j.1468-0009.2012.00678.x
5 Suijker CA. Foucault and medicine: challenging normative claims. Med Health Care Philos 2023; 26: 539–48. doi: https://doi.org/10.1007/s11019-023-10170-y
6 Porter D. Health, Civilization and the State: A History of Public Health from Ancient to Modern Times. London: Routledge. 2005. doi: https://doi.org/10.4324/9780203980576
7 Bashford A. Global biopolitics and the history of world health. History of the Human Sciences. 2006; 19: 67–88. doi: https://doi.org/10.1177/0952695106062148
8 Coulter A, Oldham J. Person-centred care: what is it and how do we get there?. Future Hosp J. 2016; 3: 114–6. doi: https://doi.org/10.7861/futurehosp.3-2-114
9 Petersen A, Lupton D. The New Public Health: Discourses, Knowledges, Strategies. SAGE Publications, 1996.
10 Agamben G. The Use of Bodies, Redwood City: Stanford University Press, 2016. doi: https://doi.org/10.1515/9780804798617
11 Ludwig G. Body politics and democracy. Constellations 2021; 28: 537–54. doi: https://doi.org/10.1111/1467-8675.12473
12 Vernon G. Books: Reimagining Global Health: An Introduction: Is Global Health a Human Right?. Br J Gen Pract. 2020; 70: 34–34. doi: https://doi.org/10.3399/bjgp20X707597
13 Holst J. Global Health – emergence, hegemonic trends and biomedical reductionism. Global Health. 2020; 16: 42. doi: https://doi.org/10.1186/s12992-020-00573-4
14 Maruthappu M, Williams C. The biomarket. Global Public Health. 2013; 8: 106–19. https://doi.org/10.1080/17441692.2012.758300
15 Waitzkin H, Jasso-Aguilar R. Medicina y salud pública al final del imperio. Divulg saúde debate. 2013; : 90–9.
16 Rolling back malaria--the next 10 years. The Lancet. 2008; 372(9645): p1193. doi: https://doi.org/10.1016/S0140-6736(08)61494-4
17 Castellanos A, Chaparro-Narváez P, Morales-Plaza CD, et al. Malaria in gold-mining areas in Colombia. Mem Inst Oswaldo Cruz. 2016; 111: 59–66. doi: https://doi.org/10.1590/0074-02760150382
18 Shimony A. Tibaldo and the hole in the calendar. New York, NY, USA : Copernicus. 1998. (accessed Oct 6, 2025). http://archive.org/details/tibaldoholeincal00shim
19 Farmer P, Kleinman A, Kim J, Basilico M. Reimagining Global Health: An Introduction. Univ of California Press. 2013. https://www.ucpress.edu/books/reimagining-global-health/paper
20 Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008; 372: 1661–9. doi: https://doi.org/10.1016/S0140-6736(08)61690-6
21 Schrecker T. The Power of Money: Global Financial Markets, National Politics, and Social Determinants of Health. In: Kay A, Williams OD, eds. Global Health Governance. London: Palgrave Macmillan UK. 2009: 160–81. doi: https://doi.org/10.1057/9780230249486_8
22 OPS/OMS | Organización Panamericana de la Salud. Convenio Marco de la OMS para el Control del Tabaco -. 2009; published online May 6. (accessed Oct 6, 2025). Available from: https://www.paho.org/es/documentos/convenio-marco-oms-para-control-tabaco
23 He H, Pan Z, Wu J, Hu C, Bai L, Lyu J. Health Effects of Tobacco at the Global, Regional, and National Levels: Results From the 2019 Global Burden of Disease Study. Nicotine & Tobacco Research. 2022; 24: 864–70. doi: https://doi.org/10.1093/ntr/ntab265
24 Roemer R, Taylor A, Lariviere J. Origins of the WHO Framework Convention on Tobacco Control. Am J Public Health. 2005; 95: 936–8. doi: https://doi.org/10.2105/AJPH.2003.025908
25 Chan KH, Xiao D, Zhou M, Peto R, Chen Z. Tobacco control in China. The Lancet Public Health. 2023; 8: e1006–15. doi: https://doi.org/10.1016/S2468-2667(23)00242-6
26 Sebrié EM, Glantz SA. Attempts to Undermine Tobacco Control: Tobacco Industry “Youth Smoking Prevention” Programs to Undermine Meaningful Tobacco Control in Latin America. Am J Public Health. 2007; 97: 1357–67. doi: https://doi.org/10.2105/AJPH.2006.094128
27 Jones K, Salzman GA. The Vaping Epidemic in Adolescents. Mo Med .2020; 117(1): 56–8. https://pmc.ncbi.nlm.nih.gov/articles/PMC7023954/
28 Malagón-Rojas J, Toloza Y, Idrovo AJ, Niederbacher-Velazquez J. Initial insights on vaping-associated illnesses in Colombia: evidence for action. J Bras Pneumol .2023; : e20230130. doi: https://doi.org/10.36416/1806-3756/e20230130
29 Mohapatra S, Wisidagama S, Schifano F. Exploring Vaping Patterns and Weight Management-Related Concerns among Adolescents and Young Adults: A Systematic Review. JCM. 2024; 13: 2896. doi: https://doi.org/10.3390/jcm13102896
30 Sebrié EM, Glantz SA. Attempts to Undermine Tobacco Control: Tobacco Industry “Youth Smoking Prevention” Programs to Undermine Meaningful Tobacco Control in Latin America. Am J Public Health. 2007; 97: 1357–67. doi: https://doi.org/10.2105/AJPH.2006.094128
31 Cruz T, Rose S, Lienemann B, Byron MJ, Meissner HI, Baezconde-Garbanati L, et al. Pro-tobacco marketing and anti-tobacco campaigns aimed atvulnerable populations: A review of the literature. Tob Induc Dis. 2019; 17. doi: https://doi.org/10.18332/tid/111397
32 Van Der Eijk Y, Bero LA, Malone RE. Philip Morris International-funded ‘Foundation for a Smoke-Free World’: analysing its claims of independence. Tob Control. 2019; 28: 712–8. doi: https://doi.org/10.1136/tobaccocontrol-2018-054278
33 Legg T, Clift B, Gilmore AB. Document analysis of the Foundation for a Smoke-Free World’s scientific outputs and activities: a case study in contemporary tobacco industry agnogenesis. Tob Control. 2024; 33: 525–34. doi: https://doi.org/10.1136/tc-2022-057667
34 University of Bath. Tobacco Industry Tactics. Tobacco Tactics. 2024. (accessed Oct 6, 2025). Available from: https://www.tobaccotactics.org/article/tobacco-industry-tactics/
35 Matthes BK, Alebshehy R, Gilmore AB. “They try to suppress us, but we should be louder”: a qualitative exploration of intimidation in tobacco control. Global Health. 2023; 19: 88. doi: https://doi.org/10.1186/s12992-023-00991-0
36 Ghosh S, Drummond MB. Electronic cigarettes as smoking cessation tool: are we there?. Current Opinion in Pulmonary Medicine. 2017; 23: 111–6. doi: https://doi.org/10.1097/MCP.0000000000000348
37 Peeters S, Gilmore AB. Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy. Tob Control. 2015; 24: 182–9. doi: https://doi.org/10.1136/tobaccocontrol-2013-051502
38 GOV.UK. Office for Health & Disparities. Smoking and tobacco: applying All Our Health.. 2025. (accessed Oct 6, 2025). Available from: https://www.gov.uk/government/publications/smoking-and-tobacco-applying-all-our-health/smoking-and-tobacco-applying-all-our-health
39 Ranjit A, McCutchan G, Brain K, Poole R. “That’s the whole thing about vaping, it’s custom tasty goodness”: a meta-ethnography of young adults’ perceptions and experiences of e-cigarette use. Subst Abuse Treat Prev Policy. 2021; 16: 85. doi: https://doi.org/10.1186/s13011-021-00416-4
40 Lindson N, Butler AR, McRobbie H, Bellen C, Hajek P, Wu AD, et al. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews. 2025; 2025. doi: https://doi.org/10.1002/14651858.CD010216.pub9
41 UK Parliament. Tobacco and Vapes Bill. 2025; published online June 10. (accessed Oct 6, 2025). Available from: https://hansard.parliament.uk/commons/2025-03-26/debates/AB0F9438-782E-4884-AFFC-0E30C18D1E36/TobaccoAndVapesBill
42 Adebisi YA, Lungu S, Curado A, Oke G, Yach D. Understanding research gaps and priorities for tobacco harm reduction in low-income and middle-income countries. Ethics, Medicine and Public Health. 2025; 33: 101117. doi: https://doi.org/10.1016/j.jemep.2025.101117
43 Garrett BE, Dube SR, Babb S, McAfee T. Addressing the Social Determinants of Health to Reduce Tobacco-Related Disparities. Nicotine & Tobacco Research. 2015; 17(8): 892–7. doi: https://doi.org/10.1093/ntr/ntu266
44 WHO. WHO report on the global tobacco epidemic, 2025: warning about the dangers of tobacco. 2025. (accessed Oct 6, 2025). https://www.who.int/publications/i/item/9789240112063
45 Malagón-Rojas J. Vaping regulation in Colombia: another success of citizenship. The Lancet Regional Health – Americas. 2024; 33: 100749. doi: https://doi.org/10.1016/j.lana.2024.100749
46 Ramadan M, Alsiary RA, Aboalola DA, Aouabdi S. Cross-Country Comparison of Bans on Internet Tobacco Advertising, and Search Interest in Vaping Products. Tobacco Use Insights. 2025; 18: doi: https://doi.org/10.1177/1179173X241275887
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2026 Jeadran Malagón-Rojas, Luis Fernando Restrepo-Pérez